A number of other research analysts have also recently commented on the company. Lake Street Capital dropped their price target on Sientra from $8.00 to $2.00 in a research report on Friday, September 16th. Craig Hallum dropped their price target on Sientra to $1.30 in a research report on Thursday, October 27th. Finally, William Blair cut Sientra from an outperform rating to a market perform rating in a report on Tuesday, October 25th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Sientra presently has an average rating of Moderate Buy and an average price target of $5.19.
Sientra Price Performance
Shares of NASDAQ SIEN opened at $0.29 on Tuesday. Sientra has a one year low of $0.16 and a one year high of $4.43. The company has a debt-to-equity ratio of 7.28, a current ratio of 1.34 and a quick ratio of 0.70. The business’s fifty day moving average price is $0.41 and its 200-day moving average price is $0.72. The stock has a market capitalization of $18.82 million, a PE ratio of -0.26 and a beta of 1.51.
Institutional Trading of Sientra
Sientra Company Profile
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
- Get a free copy of the StockNews.com research report on Sientra (SIEN)
- Why CSL Ltd Stock Could Be Worth a Look
- MarketBeat: Week in Review 11/28 – 12/02
- Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?
- Institutions Are Buying Ambarella, Should You?
- Can ZIM Defy Broad Downturn In The Container Shipping Industry?
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.